Alaunos Therapeutics, Inc. Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Alaunos Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Alaunos Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -266 %, a 120% decline year-over-year.
  • Alaunos Therapeutics, Inc. annual Return On Equity for 2023 was -197 %, a 109% decline from 2022.
  • Alaunos Therapeutics, Inc. annual Return On Equity for 2022 was -94.3 %, a 3.96% increase from 2021.
  • Alaunos Therapeutics, Inc. annual Return On Equity for 2021 was -98.2 %, a 88.1% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -266 -145 -120% Apr 1, 2024 Jun 30, 2024
Q1 2024 -230 -121 -112% Jan 1, 2024 Mar 31, 2024
Q4 2023 -197 -103 -109% Oct 1, 2023 Dec 31, 2023
Q3 2023 -141 -50.8 -56.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -121 -20.5 -20.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -108 -6.84 -6.74% Jan 1, 2023 Mar 31, 2023
Q4 2022 -94.3 +3.89 +3.96% Oct 1, 2022 Dec 31, 2022
Q3 2022 -90 +2.87 +3.09% Jul 1, 2022 Sep 30, 2022
Q2 2022 -100 -25 -33.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -101 -39.5 -63.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -98.2 -46 -88.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -92.8 -42.8 -85.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -75.5 +17.5 +18.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -61.9 +48.7 +44.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 -52.2 +87.5 +62.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -50 -163 -144% Jul 1, 2020 Sep 30, 2020
Q2 2020 -93 -998 -110% Apr 1, 2020 Jun 30, 2020
Q1 2020 -111 +316 +74.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -140 +25.1 +15.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 113 +54.2 +92.5% Jul 1, 2019 Sep 30, 2019
Q2 2019 905 +837 +1233% Apr 1, 2019 Jun 30, 2019
Q1 2019 -427 -509 -620% Jan 1, 2019 Mar 31, 2019
Q4 2018 -165 -252 -289% Oct 1, 2018 Dec 31, 2018
Q3 2018 58.6 -29.6 -33.5% Jul 1, 2018 Sep 30, 2018
Q2 2018 67.9 -20.6 -23.3% Apr 1, 2018 Jun 30, 2018
Q1 2018 82.1 -167 -67.1% Jan 1, 2018 Mar 31, 2018
Q4 2017 87.3 -508 -85.3% Oct 1, 2017 Dec 31, 2017
Q3 2017 88.2 +1.46K Jul 1, 2017 Sep 30, 2017
Q2 2017 88.5 +419 Apr 1, 2017 Jun 30, 2017
Q1 2017 250 +308 Jan 1, 2017 Mar 31, 2017
Q4 2016 595 +712 Oct 1, 2016 Dec 31, 2016
Q3 2016 -1.37K -1.24K -916% Jul 1, 2016 Sep 30, 2016
Q2 2016 -330 -186 -128% Apr 1, 2016 Jun 30, 2016
Q1 2016 -58.3 +117 +66.8% Jan 1, 2016 Mar 31, 2016
Q4 2015 -117 -31.6 -37.3% Oct 1, 2015 Dec 31, 2015
Q3 2015 -135 -61.7 -84.1% Jul 1, 2015 Sep 30, 2015
Q2 2015 -145 -21.1 -17.1% Apr 1, 2015 Jun 30, 2015
Q1 2015 -175 +13.9 +7.35% Jan 1, 2015 Mar 31, 2015
Q4 2014 -84.9 +122 +59% Oct 1, 2014 Dec 31, 2014
Q3 2014 -73.3 +214 +74.5% Jul 1, 2014 Sep 30, 2014
Q2 2014 -124 +69.7 +36.1% Apr 1, 2014 Jun 30, 2014
Q1 2014 -189 -36.5 -23.9% Jan 1, 2014 Mar 31, 2014
Q4 2013 -207 -70.3 -51.3% Oct 1, 2013 Dec 31, 2013
Q3 2013 -287 -183 -176% Jul 1, 2013 Sep 30, 2013
Q2 2013 -193 -118 -156% Apr 1, 2013 Jun 30, 2013
Q1 2013 -153 -94.5 -162% Jan 1, 2013 Mar 31, 2013
Q4 2012 -137 Oct 1, 2012 Dec 31, 2012
Q3 2012 -104 Jul 1, 2012 Sep 30, 2012
Q2 2012 -75.5 Apr 1, 2012 Jun 30, 2012
Q1 2012 -58.4 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.